Grey Market Buzz: Corona Remedies IPO Trades At 27% Premium On Day 1 Subscription
Published on: Dec. 8, 2025, 11:36 a.m. | Source: NDTV Profit
Corona Remedies Ltd. launched its initial public offering (IPO) on Monday, December 8. The Ahmedabad-based pharmaceutical company develops, manufactures and markets products across multiple therapeutic segments, including women’s health, cardiology, pain management and urology.
